Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Hillmen, P; Pettitt, A; Schuh, A; Milligan, D; Bowles, K; Bareford, D; Riaz, JM; Follows, G; Rule, S; Wallis, J; Gribben, J; Noble, R; Pocock, C; Lisby, S; Carey, J; Gupta, I; Chang, CN; McKeown, A

doi:10.1111/bjh.12802

Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Hillmen P, Pettitt A, Schuh A, Milligan D, Bowles K, Bareford D, Riaz JM, Follows G, Rule S, Wallis J, Gribben J, Noble R, Pocock C, Lisby S, Carey J, Gupta I, Chang CN, McKeown A

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 54th Annual Scientific Meeting of the British Society for Haematology

Year of Conference: 2014

Pages: 19-20

Print publication date: 01/05/2014

Online publication date: 28/04/2014

ISSN: 0007-1048

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/bjh.12802

DOI: 10.1111/bjh.12802

Notes: Abstract number 37.

Series Title: British Journal of Haematology

ePrints

Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Downloads

Publication metadata

Share